##gff-version 3
##sequence-region P25963 1 317
P25963	UniProtKB	Chain	1	317	.	.	.	ID=PRO_0000066999;Note=NF-kappa-B inhibitor alpha	
P25963	UniProtKB	Repeat	73	103	.	.	.	Note=ANK 1	
P25963	UniProtKB	Repeat	110	139	.	.	.	Note=ANK 2	
P25963	UniProtKB	Repeat	143	172	.	.	.	Note=ANK 3	
P25963	UniProtKB	Repeat	182	211	.	.	.	Note=ANK 4	
P25963	UniProtKB	Repeat	216	245	.	.	.	Note=ANK 5	
P25963	UniProtKB	Motif	30	36	.	.	.	Note=Destruction motif	
P25963	UniProtKB	Motif	45	54	.	.	.	Note=Nuclear export signal	
P25963	UniProtKB	Motif	110	120	.	.	.	Note=Nuclear import signal	
P25963	UniProtKB	Modified residue	32	32	.	.	.	Note=Phosphoserine%3B by IKKA and IKKE;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10329681,ECO:0000269|PubMed:10882136;Dbxref=PMID:10329681,PMID:10882136	
P25963	UniProtKB	Modified residue	36	36	.	.	.	Note=Phosphoserine%3B by IKKA%2C IKKB%2C IKKE and TBK1;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10329681,ECO:0000269|PubMed:10882136;Dbxref=PMID:10329681,PMID:10882136	
P25963	UniProtKB	Modified residue	42	42	.	.	.	Note=Phosphotyrosine%3B by Tyr-kinases;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8797825;Dbxref=PMID:8797825	
P25963	UniProtKB	Modified residue	210	210	.	.	.	Note=(3S)-3-hydroxyasparagine%3B by HIF1AN%3B partial;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17003112;Dbxref=PMID:17003112	
P25963	UniProtKB	Modified residue	244	244	.	.	.	Note=(3S)-3-hydroxyasparagine%3B by HIF1AN%3B partial;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17003112;Dbxref=PMID:17003112	
P25963	UniProtKB	Modified residue	283	283	.	.	.	Note=Phosphoserine%3B by CK2;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:8622692,ECO:0000269|PubMed:8657113;Dbxref=PMID:8622692,PMID:8657113	
P25963	UniProtKB	Modified residue	288	288	.	.	.	Note=Phosphoserine%3B by CK2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8622692;Dbxref=PMID:8622692	
P25963	UniProtKB	Modified residue	291	291	.	.	.	Note=Phosphothreonine%3B by CK2;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:8622692,ECO:0000269|PubMed:8657113;Dbxref=PMID:8622692,PMID:8657113	
P25963	UniProtKB	Modified residue	293	293	.	.	.	Note=Phosphoserine%3B by CK2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8622692;Dbxref=PMID:8622692	
P25963	UniProtKB	Modified residue	299	299	.	.	.	Note=Phosphothreonine%3B by CK2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8657113;Dbxref=PMID:8657113	
P25963	UniProtKB	Cross-link	21	21	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO or ubiquitin)%3B alternate;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20347421,ECO:0000269|PubMed:7479976;Dbxref=PMID:20347421,PMID:7479976	
P25963	UniProtKB	Cross-link	21	21	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9Z1E3	
P25963	UniProtKB	Cross-link	22	22	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20347421,ECO:0000269|PubMed:7479976;Dbxref=PMID:20347421,PMID:7479976	
P25963	UniProtKB	Natural variant	32	32	.	.	.	ID=VAR_034871;Note=In ADEDAID. S->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14523047;Dbxref=dbSNP:rs28933100,PMID:14523047	
P25963	UniProtKB	Mutagenesis	21	21	.	.	.	Note=Little change in Tax-stimulated transactivation. No sumoylation. Greatly reduced Tax- or cytokine-stimulated transactivation and decrease in ubiquitination and degradation%3B when associated with R-22. K->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11124955,ECO:0000269|PubMed:17956732,ECO:0000269|PubMed:7479976,ECO:0000269|PubMed:8657102;Dbxref=PMID:11124955,PMID:17956732,PMID:7479976,PMID:8657102	
P25963	UniProtKB	Mutagenesis	22	22	.	.	.	Note=Little change in Tax-stimulated transactivation. No sumoylation. Greatly reduced Tax- or cytokine-stimulated transactivation and decrease in ubiquitination and degradation%3B when associated with R-21. K->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11124955,ECO:0000269|PubMed:17956732,ECO:0000269|PubMed:7479976,ECO:0000269|PubMed:8657102;Dbxref=PMID:11124955,PMID:17956732,PMID:7479976,PMID:8657102	
P25963	UniProtKB	Mutagenesis	31	31	.	.	.	Note=Loss of phosphorylation%3B when associated with A-35. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8657102;Dbxref=PMID:8657102	
P25963	UniProtKB	Mutagenesis	32	32	.	.	.	Note=Loss of phosphorylation%2C ubiquitination and degradation%3B when associated with A-36. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10329681,ECO:0000269|PubMed:8657102;Dbxref=PMID:10329681,PMID:8657102	
P25963	UniProtKB	Mutagenesis	32	32	.	.	.	Note=Decrease in phosphorylation and degradation%3B when associated with T-36. S->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10329681,ECO:0000269|PubMed:8657102;Dbxref=PMID:10329681,PMID:8657102	
P25963	UniProtKB	Mutagenesis	35	35	.	.	.	Note=Loss in phosphorylation%3B when associated with A-31. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8657102;Dbxref=PMID:8657102	
P25963	UniProtKB	Mutagenesis	35	35	.	.	.	Note=No change neither in phosphorylation%2C nor on degradation. D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8657102;Dbxref=PMID:8657102	
P25963	UniProtKB	Mutagenesis	36	36	.	.	.	Note=Loss of phosphorylation%2C ubiquitination%2C and degradation%3B when associated with A-32. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10329681,ECO:0000269|PubMed:8657102;Dbxref=PMID:10329681,PMID:8657102	
P25963	UniProtKB	Mutagenesis	36	36	.	.	.	Note=Decrease in phosphorylation and degradation%3B when associated with T-32. S->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10329681,ECO:0000269|PubMed:8657102;Dbxref=PMID:10329681,PMID:8657102	
P25963	UniProtKB	Mutagenesis	38	38	.	.	.	Note=No change in Tax-stimulated transactivation. No change in Tax-stimulated transactivation%3B when associated with R-47. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7479976;Dbxref=PMID:7479976	
P25963	UniProtKB	Mutagenesis	42	42	.	.	.	Note=No phosphorylation. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8797825;Dbxref=PMID:8797825	
P25963	UniProtKB	Mutagenesis	45	52	.	.	.	Note=No nuclear export. MVKELQEI->AAKEAQEA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10655476;Dbxref=PMID:10655476	
P25963	UniProtKB	Mutagenesis	47	47	.	.	.	Note=Little change in Tax-stimulated transactivation. No change in Tax-stimulated transactivation%3B when associated with R-38. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7479976;Dbxref=PMID:7479976	
P25963	UniProtKB	Mutagenesis	115	120	.	.	.	Note=Greatly reduced nuclear localization. Great reduction in its ability to inhibit DNA binding of RELA. LHLAVI->AHAAVA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9566872;Dbxref=PMID:9566872	
P25963	UniProtKB	Mutagenesis	210	210	.	.	.	Note=Almost abolished ability to inhibit NF-kappa-B DNA-binding activity%3B when associated with A-244. N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17003112;Dbxref=PMID:17003112	
P25963	UniProtKB	Mutagenesis	234	234	.	.	.	Note=No inducible ubiquitination nor protein degradation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8657102;Dbxref=PMID:8657102	
P25963	UniProtKB	Mutagenesis	244	244	.	.	.	Note=Almost abolished ability to inhibit NF-kappa-B DNA-binding activity%3B when associated with A-210. N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17003112;Dbxref=PMID:17003112	
P25963	UniProtKB	Mutagenesis	262	262	.	.	.	Note=No inducible ubiquitination nor protein degradation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8657102;Dbxref=PMID:8657102	
P25963	UniProtKB	Mutagenesis	263	263	.	.	.	Note=No inducible ubiquitination nor protein degradation. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8657102;Dbxref=PMID:8657102	
P25963	UniProtKB	Turn	72	74	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1NFI	
P25963	UniProtKB	Helix	79	83	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IKN	
P25963	UniProtKB	Beta strand	87	91	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IKN	
P25963	UniProtKB	Helix	101	104	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1NFI	
P25963	UniProtKB	Helix	114	120	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IKN	
P25963	UniProtKB	Helix	124	128	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IKN	
P25963	UniProtKB	Helix	147	154	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IKN	
P25963	UniProtKB	Helix	157	165	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IKN	
P25963	UniProtKB	Turn	167	170	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IKN	
P25963	UniProtKB	Beta strand	171	173	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IKN	
P25963	UniProtKB	Helix	175	177	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IKN	
P25963	UniProtKB	Helix	186	192	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IKN	
P25963	UniProtKB	Helix	196	205	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IKN	
P25963	UniProtKB	Turn	214	216	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IKN	
P25963	UniProtKB	Helix	220	226	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IKN	
P25963	UniProtKB	Helix	230	237	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IKN	
P25963	UniProtKB	Turn	238	240	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IKN	
P25963	UniProtKB	Helix	253	256	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IKN	
P25963	UniProtKB	Helix	263	270	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IKN	
P25963	UniProtKB	Helix	275	277	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IKN	
P25963	UniProtKB	Turn	285	287	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IKN	
